Virax Biolabs Group Limited (VRAX) Stock Price, Quote & News

Company Profile

Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7788 7414

Website: viraxbiolabs.com

Address:

BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom

Homer_Simpson82 Aug. 24 at 5:55 PM

$VRAX trash

0 · Reply

KobeTheGoat Aug. 24 at 3:00 PM

$VRAX SCAM

0 · Reply

BigTimePennyStocks Aug. 23 at 11:24 PM

Small-Caps with Catalysts this week: 👇👇 ( $ANY, $CAPS, $VRAX, $HCWC, $FFAI, etc...) (Article in bio.) #NASDAQ #NYSE

0 · Reply

TraderBuckNKY Aug. 21 at 11:48 PM

$VRAX James Foster is on to something and knows what he is doing . . .

0 · Reply

Homer_Simpson82 Aug. 21 at 6:14 PM

$VRAX no why😂😂😂😂

0 · Reply

KobeTheGoat Aug. 21 at 6:12 PM

$VRAX Another Bag Holder

0 · Reply

Homer_Simpson82 Aug. 21 at 6:09 PM

$VRAX next Expert😂😂

0 · Reply

Mugu Aug. 21 at 5:21 PM

$VRAX can't miss in for more

0 · Reply

AtariLynx Aug. 21 at 5:15 PM

$VRAX KobeTheGoat James Foster wants you for dinner. 😂

0 · Reply

KobeTheGoat Aug. 21 at 4:26 PM

$VRAX DILUTED AND SCAMMED TO THE MOON...WHAT A PIECE OF SHIT RUN BY A CON!!!!! Every time there is a little green day, it's immediately ran down lower....just look at the last 2 years...from 9 bucks to reverse split straight down with a little tick up every month or so to suck in new bagholders, and boom immediately down...rinse and repeat, over and over and over again....ANYONE TELLING YOU OTHERWISE OR TELLING YOU TO BUY IS A SCAMMER AND CLUELESS....it's all there for you to clearly see...you've been warned over and over again...STOP LOSING YOUR MONEY AND BUY REAL STOCKS, NOT SCAMS!!!! can't stress it enough, PLEASE STOP LOSING!!!!

0 · Reply

Virax Biolabs files to sell 1.68M ordinary shares for holders

Jul 16, 2026, 7:30 AM EDT - 5 weeks ago

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

Jul 10, 2026, 4:05 PM EDT - 6 weeks ago

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Jul 9, 2026, 1:35 PM EDT - 6 weeks ago

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Jul 9, 2026, 12:33 PM EDT - 6 weeks ago

Why this biotech stock more than tripled on Thursday

2026-07-09T13:23:51.000Z - 6 weeks ago

Why Is Penny Stock Virax Biolabs (VRAX) Up Today?

2026-07-09T11:35:58.000Z - 6 weeks ago

Virax Biolabs signs multi-country commercial agreement with Fosun Diagnostics

Jul 9, 2026, 7:30 AM EDT - 6 weeks ago

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics

2026-06-25T23:50:16.000Z - 2 months ago

Virax Biolabs Group Ltd trading halted, news pending

2026-06-24T13:05:25.000Z - 2 months ago

Virax Biolabs approves share consolidation program

Jun 24, 2026, 9:00 AM EDT - 2 months ago

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

2026-05-26T13:04:03.000Z - 3 months ago

Virax Biolabs reports pilot data for ViraxImmune in Long COVID

May 26, 2026, 7:30 AM EDT - 3 months ago

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

2026-04-14T11:58:17.000Z - 4 months ago

Virax Biolabs CEO outlines strategic priorities, near-term milestones

Apr 14, 2026, 7:34 AM EDT - 4 months ago

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

Mar 31, 2026, 7:34 AM EDT - 5 months ago

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

2026-01-09T17:26:12.000Z - 8 months ago

Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright

2025-12-18T21:15:19.000Z - 8 months ago

Virax Biolabs files to sell 25.875M ordinary shares for holders

Dec 4, 2025, 4:05 PM EST - 9 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Dec 3, 2025, 1:53 PM EST - 9 months ago

Virax Biolabs Group Limited Announces $5 Million Private Placement

2025-12-03T13:54:57.000Z - 9 months ago

Why Is Virax Biolabs (VRAX) Stock Rocketing Higher Today?

Dec 3, 2025, 7:34 AM EST - 9 months ago

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

2025-11-03T13:36:20.000Z - 10 months ago

Virax completes patient recruitment for its clinical study evaluating ViraxImmun

Nov 3, 2025, 8:29 AM EST - 10 months ago

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

2025-08-26T11:35:28.000Z - 1 year ago

Virax Biolabs partners with Emory University on ViraxImmune clinical studies

Aug 26, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Jul 29, 2025, 7:35 AM EDT - 1 year ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

2025-07-19T02:25:41.000Z - 1 year ago

Virax Biolabs receives noncompliance notice from Nasdaq

Jul 18, 2025, 4:15 PM EDT - 1 year ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

2025-03-31T10:15:46.000Z - 1 year ago

Virax Biolabs initiated with a Buy at H.C. Wainwright

2025-03-18T11:36:57.000Z - 1 year ago

Virax Biolabs enrolls first patients in T-cell dysfunction study

Mar 18, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 1 year ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Feb 25, 2025, 7:00 AM EST - 1 year ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Jan 23, 2025, 3:35 PM EST - 1 year ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

2025-01-13T14:41:05.000Z - 1 year ago

Cosmos Health secures exclusive distribution agreement with Virax Biolabs

COSM

Jan 13, 2025, 9:20 AM EST - 1 year ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Dec 17, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

2024-12-10T12:35:42.000Z - 1 year ago

Virax Biolabs enters non-exclusive distribution agreement with Tebubio

Dec 10, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

2024-10-23T11:35:15.000Z - 1 year ago

Virax Biolabs announces distribution agreement with Europa Biosite

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

2024-09-23T13:20:29.000Z - 2 years ago

Cosmos Health enters exclusivity agreement with Virax Biolabs

COSM

Sep 16, 2024, 8:30 AM EDT - 2 years ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Sep 16, 2024, 8:30 AM EDT - 2 years ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Sep 9, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Aug 29, 2024, 9:03 AM EDT - 2 years ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 28, 2024, 2:18 PM EDT - 2 years ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 23, 2024, 4:09 PM EDT - 2 years ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 2 years ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 10:20 AM EDT - 2 years ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs to Participate at ESCMID Global 2024

Dec 21, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 14, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Sep 12, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 1, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Aug 3, 2023, 7:30 AM EDT - 3 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Jul 18, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

May 4, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Apr 19, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Mar 10, 2023, 5:17 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 3 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 7, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Feb 7, 2023, 9:15 AM EST - 3 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Feb 7, 2023, 8:30 AM EST - 3 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Feb 6, 2023, 4:05 PM EST - 3 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Homer_Simpson82 Aug. 24 at 5:55 PM

$VRAX trash

0 · Reply

KobeTheGoat Aug. 24 at 3:00 PM

$VRAX SCAM

0 · Reply

BigTimePennyStocks Aug. 23 at 11:24 PM

Small-Caps with Catalysts this week: 👇👇 ( $ANY, $CAPS, $VRAX, $HCWC, $FFAI, etc...) (Article in bio.) #NASDAQ #NYSE

0 · Reply

TraderBuckNKY Aug. 21 at 11:48 PM

$VRAX James Foster is on to something and knows what he is doing . . .

0 · Reply

Homer_Simpson82 Aug. 21 at 6:14 PM

$VRAX no why😂😂😂😂

0 · Reply

KobeTheGoat Aug. 21 at 6:12 PM

$VRAX Another Bag Holder

0 · Reply

Homer_Simpson82 Aug. 21 at 6:09 PM

$VRAX next Expert😂😂

0 · Reply

Mugu Aug. 21 at 5:21 PM

$VRAX can't miss in for more

0 · Reply

AtariLynx Aug. 21 at 5:15 PM

$VRAX KobeTheGoat James Foster wants you for dinner. 😂

0 · Reply

KobeTheGoat Aug. 21 at 4:26 PM

0 · Reply

KobeTheGoat Aug. 21 at 2:13 PM

$VRAX JUST MORE BAGHOLDERS CREATED...WHAT A SAD, SAD, SCAM THAT KEEPS SCAMMING.....went from $9 to a reverse split, straight down and people believe this is an actual company doing things....buncha dumbasses losing their money over and over again!!!! SCAM RUN BY A CON DO BETTER RESEARCH!!!

0 · Reply

TraderBuckNKY Aug. 21 at 12:10 PM

$VRAX …Think with the venture of $LLY into peptides that $VRAX might be on to something big?…maybe, even a buy-out down the road… • That market has boomed even though retatrutide is still being studied in clinical trials and hasn't been approved by the Food and Drug Administration as safe and effective. Federal law prohibits the commercial sale of unapproved drugs, but many telehealth firms, clinics and peptide vendors online have decided to offer the next-generation drug anyway, as promising results from Eli Lilly's trials have fueled a craze for it on social media. https://research.viraxbiolabs.com/?_gl=1%2A7klu0k%2A_ga%2ANTg1MzExMjc1LjE3NjM1NjgxMTQ.%2A_ga_7HT88ZY7F0%2AczE3ODczMDk2MjIkbzI2JGcwJHQxNzg3MzA5NjIyJGo2MCRsMCRoMA.. • SARS-Cov-2 (Omicron) ImmuneSelect Peptide Pool Premium • £ 175.00 • CEF Control ImmuneSelect Peptide Pool Premium • £ 175.00 • Ebola (Bundibugyo) Virus ImmuneSelect Peptide Pool Premium • £ 195.00 • ELISpot Human IFN-γ Kit + RSV peptide pool • £ 280.00 • S. pneumoniae ImmuneSelect Peptide Pool Premium • £ 150.00 • P. aeruginosa ImmuneSelect Peptide Pool Premium • £ 150.00 •

0 · Reply

chicharrotrading Aug. 21 at 11:06 AM

$CISS $VRAX 🔥 today's watchlist — 1 micro/nano-cap + 1 micro/nano-floater covered below. $CISS (micro/nano-cap #3) 🚀 strong momentum, ⚠️ elevated risk | Industrials/Marine Shipping 🔦 Chart flags a recent falling wedge pattern — 🔎 Volume running 0.01x its short-term average — sometimes coinciding with larger-participant positioning rather than routine retail flow. — 📰 C3is Inc. Q1 2026 Earnings Call Summary (Moby) $VRAX (micro/nano-floater #2) 🚀 strong momentum, ⚠️ elevated risk | Healthcare/Biotechnology ($2.7M) 📰 Virax Biolabs enters immune profiling product supply deal with Fosun (Hospital Management)

0 · Reply

bubsomatic Aug. 20 at 9:07 PM

$VRAX nice day here

0 · Reply

TraderBuckNKY Aug. 20 at 7:47 PM

$VRAX ORLANDO, FL / ACCESS Newswire / August 20, 2026 / RedChip Companies will host an investor webinar on Tuesday, August 25, 2026 , at 4:15 p.m. ET with Virax Biolabs Group Limited (Nasdaq:VRAX) ("Virax" or the "Company"). The event will feature Virax Chief Executive Officer James Foster , who will provide an overview of the Company's financial and strategic position following its fiscal 2026 annual report and discuss recent developments across the Company's ViraxImmune™ and ImmuneSelect programs. Foster will discuss ViraxImmune™, the Company's principal value platform, including its clinical evidence strategy, development pathway and planned U.S . CLIA laboratory-developed test market-entry strategy for post-acute infection syndromes, including Long COVID.

0 · Reply